• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular mechanism for transcriptional regulation of dopamine beta-hydroxylase gene.

Research Project

Project/Area Number 07670156
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field General medical chemistry
Research InstitutionFujita Health University

Principal Investigator

ISHIGURO Hiroshi  Fujita Health University, Assistant professor, 総合医科学研究所, 講師 (20211039)

Co-Investigator(Kenkyū-buntansha) NAGATSU Toshiharu  Fujita Health University, Professor, 総合医科学研究所, 教授 (40064802)
藤田 啓介  藤田保健衛生大学, 総合医科学研究所, 教授 (40209052)
Project Period (FY) 1995 – 1996
Project Status Completed (Fiscal Year 1996)
Budget Amount *help
¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 1996: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1995: ¥1,000,000 (Direct Cost: ¥1,000,000)
KeywordsDopamine beta-hydroxylase / gene expression / transcriptional regulation / protein kinase A / protein kinase C / YY-1 / ドーパミンβ水酸化酵素
Research Abstract

Dopamine beta-hydroxylase (DBH) converts dopamine to norepinephrine and is specifically expressed in noradrenergic and adrenergic neurons. Cyclic AMP response element (CRE,TGACGTCC) of human DBH gene is an essential transcriptional element in the promoter region. Downstream of this CRD,there are three important DNA elements such as YY-1 binding sequence (CCAT), E-box (GATGTG), and AP-1 like sequence (TGTGTCA) that may regulate the transcription of many genes. To identify the DNA binding proteins, 26 bp oligonucleotide (actga TGACGTCCATGTGTCAttagt) was used as a probe for the electrophoretic mobility shift assay (EMSA). According to the site-directed mutagenesis work, we found that both CRE and YY-1 binding sequence formed complexes with proteins, but E-box and AP-1 like sequences did not. The addition of CRE oligonucleotides for tyrosine hydroxylase (TH) or somatostatin genes as competitors eliminated upper-shifted bands that were formed with CRE and CRE binding protein (possibly CREB … More or ATFs). Furthermore, an excess amount of oligonucleotide which was the YY-1 binding sequence of mouse c-fos gene as a competitor, completely eliminated the intermediate-shifted band. YY-1, a ubiquitously expressed zinc finger type DNA binding protein, regulates the transcriptional level of many genes, such as several viral genes, immunoglobuline gene (kappa and mu), oncogene (c-fos and c-myc), globin gene (gamma and epsilon), and so on. Astriking characteristic of this protein is a dual function which either positive or negative effects, depending on the promoter context and the intracellular circumstance. In order to assess the function of YY-1 that bound to the CCAT motif of human DBH,transient transfection experiments were performed in the DBH-expressing neuroblastoma cells (SK-N-SH). Site-directed mutagenesis experiments showed that YY-1 positively regulated the transcriptional level of human DBH gene by adding phorbol ester (TPA). In addtion, CRE binding proteins and YY-1 needed specific direction to interact with each other by the results of luciferase assay. These data suggest that YY-1 is important in the transcriptional regulation of DBH gene by the TPA induction. To identify the TPA response DNA region (TRR) in human DBH gene promoter, deletion mutant constructs from -604bp to -171bp were prepared and these luciferase reporter genes (Luc) were transfected to SK-N-SH cells. TRR resided in the upstream of CRE between -223bp and -187bp of human DBH gene, and there were no similar sequences in other known TPA response element (TRE) sequences. In addition, we tried to identifed unknown TRE,TRR disected to three DNA regions that were -223bp to -199bp (OLI-A), -213bp to -183 (OLI-D) and -206bp to -181bp (OLI-B). First, OLI-D eliminates the OLI-63 (region from -224 to -162) and nucler protein complex. Second, OLI-D responses the TPA induction by the use of tk promoter. Furthermore OLI-D and CRE of human DBH combination enhanced the luciferase activity by TPA.Int Less

Report

(3 results)
  • 1996 Annual Research Report   Final Research Report Summary
  • 1995 Annual Research Report
  • Research Products

    (5 results)

All Other

All Publications (5 results)

  • [Publications] 石黒啓司: "Identification of a negative regulatory element in the 5'-flanking region of the human dopamine β-hydroxylasegene." Mol.Brain Res.34. 251-261 (1995)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 野村隆英: "ノルアドレナリン、アドレナリン" 神経精神薬理. 19. 94-113 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] Hiroshi Ishiguro, Kwang-Soo Kim, and Tong H.Joh: "Identification of a negative regulatory element in the 5'-flanking region of the human dopamine beta-hydroxylasegene." Mol.Brain Res.34. 251-261 (1995)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] TakaHide Nomura, Hiroshi Ishiguro, Yasumichi Hagino, and Toshiharu Nagatsu.: "Noradrenaline, Adrenaline" Japanese Journal of Neuropsychopharmacology. 19. 94-113 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1996 Final Research Report Summary
  • [Publications] 野村隆英: "ニューロトランスミッター・トゥディ" 神経精神薬理, 283 (1997)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1995-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi